rs779504604
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_002386.4(MC1R):c.104G>A(p.Cys35Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,613,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002386.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.104G>A | p.Cys35Tyr | missense_variant | Exon 1 of 1 | 6 | NM_002386.4 | ENSP00000451605.1 | ||
ENSG00000198211 | ENST00000556922.1 | c.104G>A | p.Cys35Tyr | missense_variant | Exon 1 of 5 | 2 | ENSP00000451560.1 | |||
MC1R | ENST00000555427.1 | c.104G>A | p.Cys35Tyr | missense_variant | Exon 3 of 4 | 5 | ENSP00000451760.1 | |||
MC1R | ENST00000639847.1 | c.104G>A | p.Cys35Tyr | missense_variant | Exon 3 of 3 | 5 | ENSP00000492011.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000849 AC: 21AN: 247466Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134812
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1460868Hom.: 0 Cov.: 30 AF XY: 0.0000509 AC XY: 37AN XY: 726694
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74354
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
The C35Y variant in the MC1R gene has been reported previously in association with blue eyes and blond hair in an individual who was also heterozygous for a second MC1R variant (Fargnoli et al., 2003). The C35Y has also been identified in control individuals (Fernandez et al., 2007; Ibarrola-Villava et al., 2010). The C35Y variant is observed in 8/62392 (0.01%) alleles from individuals of non-Finnish background in the ExAC dataset, and no individuals were reported to be homozygous (Lek et al., 2016). The C35Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret C35Y as a variant of uncertain significance. -
Melanoma, cutaneous malignant, susceptibility to, 5 Uncertain:1
This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 35 of the MC1R protein (p.Cys35Tyr). This variant is present in population databases (rs779504604, gnomAD 0.01%). This missense change has been observed in individual(s) with melanoma (PMID: 16809487, 16982779, 24335900, 24982914). ClinVar contains an entry for this variant (Variation ID: 430181). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MC1R protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Tyrosinase-positive oculocutaneous albinism;C1849452:SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2;C2751295:Melanoma, cutaneous malignant, susceptibility to, 5;C2751296:Increased analgesia from kappa-opioid receptor agonist, female-specific Uncertain:1
- -
bilateral breast cancer Uncertain:1
ACMG Guidelines 2015 criteria PP3 Pathogenic Supporting: 6 pathogenic predictions from EIGEN, FATHMM-MKL, M-CAP, MutationAssessor, MutationTaster and SIFT vs 4 benign predictions from DANN, DEOGEN2, MVP and REVEL. BS2 Benign Strong: Observed in healthy adults: GnomAD exomes allele count = 21 > 5 threshold for dominant gene MC1R. BP1 Benign Supporting: 44 out of 45 non-VUS missense variants in gene MC1R are benign = 97.8% > threshold of 51.0%, and 85 out of 169 clinically reported variants in gene MC1R are benign = 50.3% > threshold of 24.0%. This variant was not reported in patients with breast cancer. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at